VOLITIONRX LTD — Director's Dealing 2020

Aug 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-08-04

Reporting Person: TERRELL JASON BRADLEY MD (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-04	Common Stock	M	12500	$2.5	Acquired	62500	Direct
2020-08-04	Common Stock	F	9580	$3.55	Disposed	52920	Direct
2020-08-04	Common Stock	M	12500	$3	Acquired	65420	Direct
2020-08-04	Common Stock	F	10971	$3.55	Disposed	54449	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-04	Stock Option (Right to Buy)	$2.5	M	12500	Disposed	2020-08-18	Common Stock (12500)	Direct
2020-08-04	Stock Option (Right to Buy)	$3	M	12500	Disposed	2020-08-18	Common Stock (12500)	Direct

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.